Dr. Kenneth D. Rappaport, MD

Dr. Rappaport practices at Malcom Randall Department of Veterans Affairs Medical Center in Gainesville, Florida.

Dr. Rappaport's NPI, 1114916368, was assigned on October 20, 2005. Dr. Rappaport graduated from VCU School of Medicine in 1994. Dr. Rappaport holds Florida license ME80317.

Dr. Rappaport's primary practice is Malcom Randall Department of Veterans Affairs Medical Center, at 1601 Sw Archer Rd, Gainesville, FL 32608. The practice phone is (866) 793-4591.

Dr. Rappaport's primary practice is Malcom Randall Department of Veterans Affairs Medical Center in Gainesville, Florida. Dmand AI also links Dr. Rappaport to 1 physician office and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rappaport practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Rappaport's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Rappaport is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Rappaport is licensed in Florida.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, hereditary corneal conditions, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Rappaport treats.

CMS data shows 1,261 Medicare services from Dr. Rappaport across 8 procedure codes in 2024, for 114 Medicare patients. Medicare paid $272,188 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Dr. Rappaport in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rappaport's median patient age at 66, with 41% women.

In 2024, Dr. Rappaport wrote 130 Medicare Part D claims for 16 patients. 55% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $78,605 in total drug cost. In 2023, CMS named 48 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rappaport for performance year 2024, reported individually. Dr. Rappaport accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Rappaport. Dr. Rappaport has published most often in Retina. Dr. Rappaport's most frequent co-author is Kakarla V. Chalam, MD.

CMS Open Payments shows 55 general payments to Dr. Rappaport from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $395.

Dmand AI lists 1 award for Dr. Rappaport.

Dr. Rappaport graduated from VCU School of Medicine in 1994. Dr. Rappaport is a member of AAO.

Dr. Rappaport is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.